Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
3 papersQuestions on this topic
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Jinhua Bao, Yingying Huang, Xue Li et al. · JAMA Ophthalmology · 2022 · Randomised trial
Full textCC BY
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono et al. · NEJM Evidence · 2022 · Randomised trial
Full textCC BY